Company
Neuraxis, INC (NRXS)
Standardized SEC financial data for Neuraxis, INC — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001933567 · NYSE · Electromedical & Electrotherapeutic Apparatus.
Gross margin
84.2%
Operating margin
-219.4%
Net margin
-218.6%
Revenue growth (YoY)
32.9%
Return on equity
-229.5%
Free cash flow
-$6.5M
Debt / equity
0.07×
Current ratio
2.05×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $2.7M | $2.5M | $2.7M | $3.6M |
| Cost of revenue | $297K | $303K | $362K | $563K |
Balance sheet
| USD | FY2021 | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | $254K | $761K | $79K | $3.7M | $5.0M |
| Inventory |
Cash flow
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | -$2.3M | -$6.7M | -$6.1M | -$6.4M |
| Capital expenditures | $1K | $31K | $28K | $31K |
Get NRXS data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/NRXS/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/NRXS/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"